Literature DB >> 3126575

Clonal characteristics of posttransplant lymphoproliferative disorders.

M A Nalesnik1, J Locker, R Jaffe, A J Demetris, K Hartle, J A Burnham, L Makowka, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3126575      PMCID： PMC3006673     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

1.  Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula.

Authors:  J E Murray; R E Wilson; N L Tilney; J P Merrill; W C Cooper; A G Birtch; C B Carpenter; E B Hager; G J Dammin; J H Harrison
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

2.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  The isolation of high molecular weight DNA from whole organisms or large tissue masses.

Authors:  D E Graham
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

Review 5.  Defective immune surveillance in viral carcinogenesis.

Authors:  D T Purtilo
Journal:  Lab Invest       Date:  1984-10       Impact factor: 5.662

6.  Variable methylation of the ribosomal RNA genes of the rat.

Authors:  L Kunnath; J Locker
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

7.  Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas.

Authors:  M L Cleary; J Sklar
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

8.  Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.

Authors:  A K Saemundsen; D T Purtilo; K Sakamoto; J L Sullivan; A C Synnerholm; D Hanto; R Simmons; M Anvret; R Collins; G Klein
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

10.  Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

Authors:  G Frizzera; D W Hanto; K J Gajl-Peczalska; J Rosai; R W McKenna; R K Sibley; K P Holahan; L L Lindquist
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701
View more
  4 in total

Review 1.  The role of EBV in post-transplant malignancies: a review.

Authors:  P Hopwood; D H Crawford
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  The surgical implications of the posttransplant lymphoproliferative disorders.

Authors:  A O Stieber; O Boillot; C Scotti-Foglieni; M A Nalesnik; R D Gordon; I Marino; V Mazzaferro; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

Review 4.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.